Tofflon Science and Technology Group Co., Ltd. engages in the research, development, production, sales, and services of pharmaceutical equipment in China and internationally. The company offers technological research, including cell technology, complex preparation, injection, and OSD laboratory; instruments comprising cell therapy and nucleic acid drugs instruments, laboratory facilities, and table reactor; single use technology that include bioreactors, liquid distribution systems, sterile bags, process chromatography, membrane filtration systems, and others; and cryopreservation system for seeds and biological samples, as well as freeze-thaw system of biological stock solutions. It also provides culture medium, such as cell and gene therapy, biomacromolecule drugs, tobitec feeding medium, and other series; bioreactors, fermentation systems, cell factory, perfusion, and complementary systems; preparation systems, including bio-process vessel and piping, common solutions preparation, and complex injectable formulation systems; and separation and purification systems comprising disc centrifuge, membrane filtration, chromatography system and columns, alkali lysis, slurry tank, and filters. In addition, the company offers resins, API, cleaning and sterilization, filling line, and OSD products and services. Further, it provides freeze-drying systems that include laboratory, production, and special application freeze-drying products, as well as loading and unloading system; packaging systems, such as packaging solutions, cartoner machine, top-load cartoner machines, blister machine, solid bottling equipment, labelling machine, and case packer with palletizer machines; isolator and inspection systems; and engineering services. The company was formerly known as Shanghai Tofflon Science and Technology Co., Ltd. Tofflon Science and Technology Group Co., Ltd. was founded in 1993 and is headquartered in Shanghai, China.
